InvestorsHub Logo
icon url

LaurieM

01/26/20 4:55 PM

#15485 RE: rayovacAAA #15483

YES! NTRPs Past reverse makes the stock a wonderful buy for new shareholders that believe in the companies mission. Good for NTRP and good for Alkon for staying the course and now with $35 million in the bank. Ha, the reverse is old old news but it is very good news for those wanting a solid opportunity at a great investment! Good for NTRP for executing a successful reverse, good for management for staying the course and good for management for keeping its listing. Start up biotechs are not an easy endeavor, NTRP is now positioned beautifully for acquisition and or upcoming trials! $35 million and reverse is behind us! Great news!
icon url

LaurieM

01/26/20 10:45 PM

#15490 RE: rayovacAAA #15483

NTRP is NOT a pump and dump, in fact the farthest thing from it. Fact, the reverse split (over a year ago) gives shareholders a unique opportunity to buy in at an amazing price with relatively few shares outstanding. OLD..... REVERSE IS NOW OUR FRIEND!